table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Oncology Drug Discovery Services Market Size Analysis from 2022 to 2027
1.5.1 Global Oncology Drug Discovery Services Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Oncology Drug Discovery Services Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Oncology Drug Discovery Services Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Oncology Drug Discovery Services Industry Impact
Chapter 2 Global Oncology Drug Discovery Services Competition by Types, Applications, and Top Regions and Countries
2.1 Global Oncology Drug Discovery Services (Volume and Value) by Type
2.1.1 Global Oncology Drug Discovery Services Consumption and Market Share by Type (2016-2021)
2.1.2 Global Oncology Drug Discovery Services Revenue and Market Share by Type (2016-2021)
2.2 Global Oncology Drug Discovery Services (Volume and Value) by Application
2.2.1 Global Oncology Drug Discovery Services Consumption and Market Share by Application (2016-2021)
2.2.2 Global Oncology Drug Discovery Services Revenue and Market Share by Application (2016-2021)
2.3 Global Oncology Drug Discovery Services (Volume and Value) by Regions
2.3.1 Global Oncology Drug Discovery Services Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Oncology Drug Discovery Services Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Oncology Drug Discovery Services Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Oncology Drug Discovery Services Consumption by Regions (2016-2021)
4.2 North America Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
4.10 South America Oncology Drug Discovery Services Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Oncology Drug Discovery Services Market Analysis
5.1 North America Oncology Drug Discovery Services Consumption and Value Analysis
5.1.1 North America Oncology Drug Discovery Services Market Under COVID-19
5.2 North America Oncology Drug Discovery Services Consumption Volume by Types
5.3 North America Oncology Drug Discovery Services Consumption Structure by Application
5.4 North America Oncology Drug Discovery Services Consumption by Top Countries
5.4.1 United States Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
5.4.2 Canada Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
5.4.3 Mexico Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 6 East Asia Oncology Drug Discovery Services Market Analysis
6.1 East Asia Oncology Drug Discovery Services Consumption and Value Analysis
6.1.1 East Asia Oncology Drug Discovery Services Market Under COVID-19
6.2 East Asia Oncology Drug Discovery Services Consumption Volume by Types
6.3 East Asia Oncology Drug Discovery Services Consumption Structure by Application
6.4 East Asia Oncology Drug Discovery Services Consumption by Top Countries
6.4.1 China Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
6.4.2 Japan Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
6.4.3 South Korea Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 7 Europe Oncology Drug Discovery Services Market Analysis
7.1 Europe Oncology Drug Discovery Services Consumption and Value Analysis
7.1.1 Europe Oncology Drug Discovery Services Market Under COVID-19
7.2 Europe Oncology Drug Discovery Services Consumption Volume by Types
7.3 Europe Oncology Drug Discovery Services Consumption Structure by Application
7.4 Europe Oncology Drug Discovery Services Consumption by Top Countries
7.4.1 Germany Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.2 UK Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.3 France Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.4 Italy Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.5 Russia Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.6 Spain Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.7 Netherlands Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.8 Switzerland Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
7.4.9 Poland Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 8 South Asia Oncology Drug Discovery Services Market Analysis
8.1 South Asia Oncology Drug Discovery Services Consumption and Value Analysis
8.1.1 South Asia Oncology Drug Discovery Services Market Under COVID-19
8.2 South Asia Oncology Drug Discovery Services Consumption Volume by Types
8.3 South Asia Oncology Drug Discovery Services Consumption Structure by Application
8.4 South Asia Oncology Drug Discovery Services Consumption by Top Countries
8.4.1 India Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
8.4.2 Pakistan Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Oncology Drug Discovery Services Market Analysis
9.1 Southeast Asia Oncology Drug Discovery Services Consumption and Value Analysis
9.1.1 Southeast Asia Oncology Drug Discovery Services Market Under COVID-19
9.2 Southeast Asia Oncology Drug Discovery Services Consumption Volume by Types
9.3 Southeast Asia Oncology Drug Discovery Services Consumption Structure by Application
9.4 Southeast Asia Oncology Drug Discovery Services Consumption by Top Countries
9.4.1 Indonesia Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
9.4.2 Thailand Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
9.4.3 Singapore Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
9.4.4 Malaysia Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
9.4.5 Philippines Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
9.4.6 Vietnam Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
9.4.7 Myanmar Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 10 Middle East Oncology Drug Discovery Services Market Analysis
10.1 Middle East Oncology Drug Discovery Services Consumption and Value Analysis
10.1.1 Middle East Oncology Drug Discovery Services Market Under COVID-19
10.2 Middle East Oncology Drug Discovery Services Consumption Volume by Types
10.3 Middle East Oncology Drug Discovery Services Consumption Structure by Application
10.4 Middle East Oncology Drug Discovery Services Consumption by Top Countries
10.4.1 Turkey Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.3 Iran Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.5 Israel Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.6 Iraq Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.7 Qatar Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.8 Kuwait Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
10.4.9 Oman Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 11 Africa Oncology Drug Discovery Services Market Analysis
11.1 Africa Oncology Drug Discovery Services Consumption and Value Analysis
11.1.1 Africa Oncology Drug Discovery Services Market Under COVID-19
11.2 Africa Oncology Drug Discovery Services Consumption Volume by Types
11.3 Africa Oncology Drug Discovery Services Consumption Structure by Application
11.4 Africa Oncology Drug Discovery Services Consumption by Top Countries
11.4.1 Nigeria Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
11.4.2 South Africa Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
11.4.3 Egypt Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
11.4.4 Algeria Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
11.4.5 Morocco Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 12 Oceania Oncology Drug Discovery Services Market Analysis
12.1 Oceania Oncology Drug Discovery Services Consumption and Value Analysis
12.2 Oceania Oncology Drug Discovery Services Consumption Volume by Types
12.3 Oceania Oncology Drug Discovery Services Consumption Structure by Application
12.4 Oceania Oncology Drug Discovery Services Consumption by Top Countries
12.4.1 Australia Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
12.4.2 New Zealand Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 13 South America Oncology Drug Discovery Services Market Analysis
13.1 South America Oncology Drug Discovery Services Consumption and Value Analysis
13.1.1 South America Oncology Drug Discovery Services Market Under COVID-19
13.2 South America Oncology Drug Discovery Services Consumption Volume by Types
13.3 South America Oncology Drug Discovery Services Consumption Structure by Application
13.4 South America Oncology Drug Discovery Services Consumption Volume by Major Countries
13.4.1 Brazil Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
13.4.2 Argentina Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
13.4.3 Columbia Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
13.4.4 Chile Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
13.4.5 Venezuela Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
13.4.6 Peru Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
13.4.8 Ecuador Oncology Drug Discovery Services Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Oncology Drug Discovery Services Business
14.1 Charles River
14.1.1 Charles River Company Profile
14.1.2 Charles River Oncology Drug Discovery Services Product Specification
14.1.3 Charles River Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 ChemPartner
14.2.1 ChemPartner Company Profile
14.2.2 ChemPartner Oncology Drug Discovery Services Product Specification
14.2.3 ChemPartner Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GenScript
14.3.1 GenScript Company Profile
14.3.2 GenScript Oncology Drug Discovery Services Product Specification
14.3.3 GenScript Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Evotec
14.4.1 Evotec Company Profile
14.4.2 Evotec Oncology Drug Discovery Services Product Specification
14.4.3 Evotec Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Zumutor
14.5.1 Zumutor Company Profile
14.5.2 Zumutor Oncology Drug Discovery Services Product Specification
14.5.3 Zumutor Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 GE Healthcare Life Sciences
14.6.1 GE Healthcare Life Sciences Company Profile
14.6.2 GE Healthcare Life Sciences Oncology Drug Discovery Services Product Specification
14.6.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Onconova
14.7.1 Onconova Company Profile
14.7.2 Onconova Oncology Drug Discovery Services Product Specification
14.7.3 Onconova Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 TCG Lifesciences
14.8.1 TCG Lifesciences Company Profile
14.8.2 TCG Lifesciences Oncology Drug Discovery Services Product Specification
14.8.3 TCG Lifesciences Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Horizon Discovery
14.9.1 Horizon Discovery Company Profile
14.9.2 Horizon Discovery Oncology Drug Discovery Services Product Specification
14.9.3 Horizon Discovery Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Aquila BioMedical
14.10.1 Aquila BioMedical Company Profile
14.10.2 Aquila BioMedical Oncology Drug Discovery Services Product Specification
14.10.3 Aquila BioMedical Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Envigo
14.11.1 Envigo Company Profile
14.11.2 Envigo Oncology Drug Discovery Services Product Specification
14.11.3 Envigo Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 HD Biosciences
14.12.1 HD Biosciences Company Profile
14.12.2 HD Biosciences Oncology Drug Discovery Services Product Specification
14.12.3 HD Biosciences Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Vichem Chemie
14.13.1 Vichem Chemie Company Profile
14.13.2 Vichem Chemie Oncology Drug Discovery Services Product Specification
14.13.3 Vichem Chemie Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 DiverChim
14.14.1 DiverChim Company Profile
14.14.2 DiverChim Oncology Drug Discovery Services Product Specification
14.14.3 DiverChim Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Syncom
14.15.1 Syncom Company Profile
14.15.2 Syncom Oncology Drug Discovery Services Product Specification
14.15.3 Syncom Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 GVK Biosciences
14.16.1 GVK Biosciences Company Profile
14.16.2 GVK Biosciences Oncology Drug Discovery Services Product Specification
14.16.3 GVK Biosciences Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 WuXi AppTec
14.17.1 WuXi AppTec Company Profile
14.17.2 WuXi AppTec Oncology Drug Discovery Services Product Specification
14.17.3 WuXi AppTec Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Aurora
14.18.1 Aurora Company Profile
14.18.2 Aurora Oncology Drug Discovery Services Product Specification
14.18.3 Aurora Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 NuChem Therapeutics
14.19.1 NuChem Therapeutics Company Profile
14.19.2 NuChem Therapeutics Oncology Drug Discovery Services Product Specification
14.19.3 NuChem Therapeutics Oncology Drug Discovery Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Oncology Drug Discovery Services Market Forecast (2022-2027)
15.1 Global Oncology Drug Discovery Services Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Oncology Drug Discovery Services Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Oncology Drug Discovery Services Value and Growth Rate Forecast (2022-2027)
15.2 Global Oncology Drug Discovery Services Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Oncology Drug Discovery Services Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Oncology Drug Discovery Services Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Oncology Drug Discovery Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Oncology Drug Discovery Services Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Oncology Drug Discovery Services Consumption Forecast by Type (2022-2027)
15.3.2 Global Oncology Drug Discovery Services Revenue Forecast by Type (2022-2027)
15.3.3 Global Oncology Drug Discovery Services Price Forecast by Type (2022-2027)
15.4 Global Oncology Drug Discovery Services Consumption Volume Forecast by Application (2022-2027)
15.5 Oncology Drug Discovery Services Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
